ResMed Inc.
RMD
$251.69
$3.111.25%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 365.04M | 344.62M | 311.36M | 292.24M | 300.49M |
Total Depreciation and Amortization | 45.65M | 49.50M | 47.25M | 47.99M | 47.88M |
Total Amortization of Deferred Charges | 6.26M | 6.40M | 6.46M | 6.77M | 6.76M |
Total Other Non-Cash Items | 29.43M | 23.00M | 19.87M | 36.00M | 6.08M |
Change in Net Operating Assets | 132.28M | -114.90M | -59.40M | 57.13M | 40.81M |
Cash from Operations | 578.66M | 308.62M | 325.54M | 440.11M | 402.03M |
Capital Expenditure | -20.80M | -20.64M | -17.84M | -24.88M | -21.19M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | 0.00 | -670.00K | -- | -19.70M | -3.08M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -10.99M | -15.38M | 19.99M | -1.93M | -8.88M |
Cash from Investing | -31.79M | -36.69M | 2.15M | -46.51M | -33.15M |
Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
Total Debt Repaid | 0.00 | -5.00M | -30.00M | -300.00M | -220.00M |
Issuance of Common Stock | 9.02M | 26.88M | 8.38M | 27.70M | 4.89M |
Repurchase of Common Stock | -75.39M | -91.72M | -50.39M | -50.43M | -50.31M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -77.70M | -77.70M | -77.89M | -70.55M | -70.49M |
Other Financing Activities | 0.00 | 0.00 | -855.00K | 0.00 | 0.00 |
Cash from Financing | -144.07M | -147.54M | -150.76M | -393.28M | -335.91M |
Foreign Exchange rate Adjustments | 7.96M | -28.81M | 11.07M | 129.00K | -5.30M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 410.77M | 95.58M | 188.00M | 451.00K | 27.66M |